Multiple sclerosis: In situ evidence for antibody and complement-mediated demyelination

被引:335
|
作者
Storch, MK
Piddlesden, S
Haltia, M
Iivanainen, M
Morgan, P
Lassmann, H
机构
[1] Univ Vienna, Inst Neurol, A-1090 Vienna, Austria
[2] Univ Wales Coll Med, Dept Biochem Med, Cardiff CF4 4XN, S Glam, Wales
[3] Univ Helsinki, Dept Pathol, Helsinki, Finland
[4] Univ Helsinki, Dept Child Neurol, Helsinki, Finland
关键词
D O I
10.1002/ana.410430409
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
We describe a case of multiple sclerosis characterized by deposition of immunoglobulin and complement in the areas of active demyelination. This was particularly evident for the C9neo antigen, which is a marker for the activated lyric complement complex and was exclusively deposited in the areas of active myelin destruction. In addition, macrophages in the lesions contained degradation products that were immunoreactive for myelin antigens, immunoglobulins, and C9neo antigen. Destruction of myelin sheaths was associated with incomplete loss of oligodendrocytes in the active areas and reappearance of oligodendrocytes with remyelination in the inactive plaque center.
引用
收藏
页码:465 / 471
页数:7
相关论文
共 50 条
  • [1] Antibody and complement-mediated glial response and demyelination
    Berg, C.
    Khorooshi, R.
    Asgari, N.
    Linington, C.
    Morgan, P. B.
    Owens, T.
    GLIA, 2015, 63 : E361 - E362
  • [2] Intravenous immunoglobulin inhibits antibody/complement-mediated demyelination
    Harrer, M.
    Fischer, K.
    Goebels, N.
    JOURNAL OF NEUROLOGY, 2010, 257 : S225 - S225
  • [3] Intravenous immunoglobulin completely inhibits demyelination in an antibody/complement-mediated model of CNS damage
    Harrer, M.
    Goebels, N.
    MULTIPLE SCLEROSIS, 2009, 15 (09): : S190 - S190
  • [4] COMPLEMENT-MEDIATED DEMYELINATION IN PATIENTS WITH IGM MONOCLONAL GAMMOPATHY AND POLYNEUROPATHY
    MONACO, S
    BONETTI, B
    FERRARI, S
    MORETTO, G
    NARDELLI, E
    TEDESCO, F
    MOLLNES, TE
    NOBILEORAZIO, E
    MANFREDINI, E
    BONAZZI, L
    RIZZUTO, N
    NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (10): : 649 - 652
  • [5] COMPLEMENT-MEDIATED DISSOCIATION OF ANTIBODY FROM ANTIGEN
    MILLER, GW
    FEDERATION PROCEEDINGS, 1977, 36 (03) : 1282 - 1282
  • [6] Antibody- and complement-mediated effector functions
    Luenemann, J.
    Bennett, J. L.
    Mantegazza, R.
    MULTIPLE SCLEROSIS JOURNAL, 2019, 25 : 69 - 69
  • [7] COMPLEMENT-MEDIATED ALTERATION OF ANTIBODY SPECIFICITY INVIVO
    DRAKE, WP
    MARDINEY, MR
    JOURNAL OF IMMUNOLOGY, 1975, 114 (03): : 1052 - 1057
  • [8] COMPLEMENT-MEDIATED DISSOCIATION OF ANTIBODY FROM IMMOBILIZED ANTIGEN
    MILLER, GW
    JOURNAL OF IMMUNOLOGY, 1977, 119 (02): : 488 - 493
  • [9] SUSCEPTIBILITY OF MOUSE TROPHOBLAST TO ANTIBODY AND COMPLEMENT-MEDIATED DAMAGE
    ZUCKERMANN, F
    HEAD, JR
    TRANSPLANTATION PROCEEDINGS, 1985, 17 (01) : 925 - 927
  • [10] ROLE OF ANTIBODY IN COMPLEMENT-MEDIATED KILLING OF TRITRICHOMONAS FETUS
    AYDINTUG, MK
    WIDDERS, PR
    JOURNAL OF LEUKOCYTE BIOLOGY, 1988, 44 (04) : 263 - 263